1.
Barna M, Uomo I, Pastorello M. Oral Agents for Treatment of Patients with Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?. JOP [Internet]. 10Jan.2013 [cited 20Apr.2024];14(1):102-4. Available from: http://www.serena.unina.it/index.php/jop/article/view/1354